Overview
Status
Active
Registry date
2024-10-28
Share capital
5,000.00 PLN
Registered address
ul. Bernatówka 58, 21-003 Dys, Poland
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202501/06/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles27,615 / 29,939
Top 92%
Results vs industry
Revenue
This companyUSD 6.32kMedianUSD 1.07mAverageUSD 22.39m
Net profit
This companyUSD 3.53kMedianUSD 37.46kAverageUSD 877.59k
Operating costs
This companyUSD 2.25kMedianUSD 932.14kAverageUSD 21.07m
Assets
This companyUSD 8.98kMedianUSD 609.79kAverageUSD 11.84m
Industry
Authorized Representatives
Agata Karolina Fijewska-Pajdowskaage 50 – Management Board Member
Jakub Paweł Pajdowskiage 47 – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $675.31 | 50% | |
Jakub Paweł Pajdowskiage 47 | 50 | $675.31 | 50% |
Agata Karolina Fijewska Pajdowska and Jakub Paweł Pajdowski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-11-07.
40 1020 3147 0000 8502 0228 8579
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| PetnovellS.A. | $0.00 | petnovell.pl | ||
| Dental Łukasiksp. j. | – | dental.lublin.pl |
FAQ
The main business activity of Orthoavanti focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 28, 2024.
The headquarters is located at: ul. Bernatówka 58, 21-003 Dys.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from October 24, 2024 to December 31, 2025.
In 2025, the company's revenue reached $6,325.
Yes, in 2025 the company was profitable, achieving a net profit of $3,527.
The largest operating cost category falls under external services. This category amounted to $1,885 in 2025, representing 84% of all operating expenses.
Last updated: 2026-06-12